ASCO’s First-Ever Clinical Trial: The TAPUR Study

July 28th 2016

The Targeted Agent and Profiling Utilization Registry (TAPUR) study is evaluating molecularly targeted cancer drugs and collecting data on clinical outcomes to learn about additional uses of these drugs outside of indications already approved by the FDA. Learn more at http://www.tapur.org

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: